Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Vaping 1 Uterine Cervical Dysplasia 1 Smoking Cessation 1 Pain 1 Nevus, Spindle Cell 1 Nevus, Pigmented 1 Nevus, Epithelioid and Spindle Cell 1 Nevus, Blue 1 Nevus 1 Neoplasms 1 Mycosis Fungoides 1 Melanoma 1 Lymphoma, T-Cell, Cutaneous 1 Dysplastic Nevus Syndrome 1 Cutaneous Squamous Cell Carcinoma 1 Breast Neoplasms 1 Agnosia 1

Interventions

Bupivacaine 11 Ketamine 9 Ropivacaine 8 Morphine 8 Acetaminophen 8 Fentanyl 7 Dexmedetomidine 7 Lidocaine 6 Anesthesia, General 6 Analgesics, Opioid 6 Saline Solution 5 Anesthesia, Local 5 Acupuncture Therapy 5 parecoxib 4 Tramadol 4 Sodium Chloride 4 Pregabalin 4 Ethanol 4 Analgesia, Epidural 4 Transcutaneous Electric Nerve Stimulation 3 Radiofrequency Ablation 3 Propofol 3 Oxycodone 3 Ketorolac 3 Control Groups 3 Anesthetics, Local 3 trimebutine 3-thiocarbamoylbenzenesulfonate 2 Therapeutics 2 Surveys and Questionnaires 2 Magnesium Sulfate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Agnosia × Transdermal Patch × Clear all

NCT06807164 2026-03-27

SerCaBot

Centre Oscar Lambret

Phase 2 Recruiting

Agnosia, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡